pyridostigmine bromide has been researched along with Cardiomyopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, MX; Liu, JJ; Liu, LZ; Lu, Y; Wu, Q; Yu, XJ; Zang, WJ | 1 |
| Alves, AC; Britto, CF; Capitelli, CS; da Silva, VJ; de Campos, HS; de Cuba, MB; de Oliveira, LF; Faleiros, AC; Farnesi, TS; Gomes, NL; Kappel, HB; Lages-Silva, E; Leite, CF; Machado, JR; Machado, MP; Martins, LA; Montano, N; Moreira, OC; Paiva, L; Ramirez, LE; Rodrigues, V; Savino, W; Silva, MV | 1 |
2 other study(ies) available for pyridostigmine bromide and Cardiomyopathies
| Article | Year |
|---|---|
Pyridostigmine protects against cardiomyopathy associated with adipose tissue browning and improvement of vagal activity in high-fat diet rats.
Topics: Adipose Tissue; Animals; Cardiomyopathies; Dietary Fats; Lipid Metabolism; Male; Muscle Proteins; Pyridostigmine Bromide; Rats; Rats, Sprague-Dawley; Signal Transduction; Vagus Nerve | 2018 |
Effects of cholinergic stimulation with pyridostigmine bromide on chronic chagasic cardiomyopathic mice.
Topics: Animals; Cardiomyopathies; Chagas Disease; Cholinesterase Inhibitors; Chronic Disease; Electrocardiography; Heart Rate; Interferon-gamma; Male; Mice; Mice, Inbred C57BL; Pyridostigmine Bromide; Trypanosoma cruzi | 2014 |